Abbott Laboratories faces a $70 million jury verdict in Illinois over alleged failure to warn about risks linked to its ...
Most of what we do, from incubators to ventilators, simply buys time and treats complications while premature infants grow.
Earlier in April 2026, a Chicago jury ordered Abbott Laboratories to pay US$70 million in compensatory and punitive damages ...
Whether Abbott Laboratories (NYSE: ABT) stock is at a good entry point depends on your investment horizon and tolerance for ...
Lower EPS guidance reflects acquisition impact, while diagnostics growth and $11.2 billion quarterly sales slightly beat expectations.
Abbott Laboratories’ shares fell after cutting its yearly profit guidance to adjust for the impact of a $21 billion ...
Abbott Laboratories continues to grapple with falling sales in its nutrition segment.
Four mothers in Chicago have been awarded $70m by a jury after their premature infants developed necrotising enterocolitis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results